SG11201406119WA - Combination treatment comprising sulphated glycosaminoglycans for inducing labor - Google Patents

Combination treatment comprising sulphated glycosaminoglycans for inducing labor

Info

Publication number
SG11201406119WA
SG11201406119WA SG11201406119WA SG11201406119WA SG11201406119WA SG 11201406119W A SG11201406119W A SG 11201406119WA SG 11201406119W A SG11201406119W A SG 11201406119WA SG 11201406119W A SG11201406119W A SG 11201406119WA SG 11201406119W A SG11201406119W A SG 11201406119WA
Authority
SG
Singapore
Prior art keywords
combination treatment
inducing labor
sulphated glycosaminoglycans
sulphated
glycosaminoglycans
Prior art date
Application number
SG11201406119WA
Other languages
English (en)
Inventor
Gunvor Ekman-Ordeberg
Anders Malmström Malmström
Original Assignee
Dilafor Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dilafor Ab filed Critical Dilafor Ab
Publication of SG11201406119WA publication Critical patent/SG11201406119WA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727Heparin; Heparan
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • A61K38/095Oxytocins; Vasopressins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11201406119WA 2012-03-26 2013-03-25 Combination treatment comprising sulphated glycosaminoglycans for inducing labor SG11201406119WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261615398P 2012-03-26 2012-03-26
PCT/SE2013/050332 WO2013147689A1 (en) 2012-03-26 2013-03-25 Combination treatment comprising sulphated glycosaminoglycans for inducing labor

Publications (1)

Publication Number Publication Date
SG11201406119WA true SG11201406119WA (en) 2014-11-27

Family

ID=49260783

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201406119WA SG11201406119WA (en) 2012-03-26 2013-03-25 Combination treatment comprising sulphated glycosaminoglycans for inducing labor

Country Status (15)

Country Link
US (1) US20150045322A1 (enExample)
EP (1) EP2830635A4 (enExample)
JP (1) JP6234989B2 (enExample)
CN (1) CN104203256B (enExample)
AU (1) AU2013240597A1 (enExample)
CA (1) CA2868444A1 (enExample)
HK (1) HK1203369A1 (enExample)
IL (1) IL234689A0 (enExample)
MX (1) MX2014011505A (enExample)
MY (1) MY175743A (enExample)
RU (1) RU2014143017A (enExample)
SG (1) SG11201406119WA (enExample)
UA (1) UA117908C2 (enExample)
WO (1) WO2013147689A1 (enExample)
ZA (1) ZA201406901B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2794665T3 (da) 2011-12-19 2018-01-29 Dilafor Ab Ikke-antikoagulative glycosaminoglycaner omfattende disaccharid-gentagelsesenhed og medicinsk anvendelse deraf
WO2013095215A1 (en) 2011-12-19 2013-06-27 Dilaforette Ab Low anticoagulant heparins
AU2013260209A1 (en) * 2012-05-08 2014-11-20 Dilafor Ab Treatment of postpartum haemorrhage with chemically modified heparin or heparan sulphate and a uterotonic agent
CA3169421A1 (en) 2020-02-17 2021-08-26 Dilafor Ab Tafoxiparin for the treatment of preeclampsia
JP2025514038A (ja) 2022-05-03 2025-05-02 ディラフォール アクチエボラグ タフォキシパリンの新規な医学的使用
EP4272749A1 (en) 2022-05-03 2023-11-08 Dilafor AB New medical use of tafoxiparin

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2614026B1 (fr) * 1987-04-16 1992-04-17 Sanofi Sa Heparines de bas poids moleculaire, a structure reguliere, leur preparation et leurs applications biologiques
US5744457A (en) * 1995-03-31 1998-04-28 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5993810A (en) * 1996-03-15 1999-11-30 Lebovitz; Shamir Israel Method of softening or ripening the cervix of a female mammal using collagenase
SE521676C2 (sv) * 2002-01-02 2003-11-25 Dilafor Ab Användning av glykosaminoglykaner för prevention och behandling av värksvaghet vid fullgången graviditet
WO2009073184A1 (en) * 2007-12-03 2009-06-11 Florida State University Research Foundation, Inc. Compositions for inducing labor and associated methods
EP2786233A1 (en) * 2011-11-28 2014-10-08 Corning Incorporated Robust optical touch-screen systems and methods using a planar transparent sheet
DK2794665T3 (da) * 2011-12-19 2018-01-29 Dilafor Ab Ikke-antikoagulative glycosaminoglycaner omfattende disaccharid-gentagelsesenhed og medicinsk anvendelse deraf

Also Published As

Publication number Publication date
MX2014011505A (es) 2014-12-05
AU2013240597A1 (en) 2014-10-16
JP6234989B2 (ja) 2017-11-22
CN104203256B (zh) 2017-11-24
EP2830635A1 (en) 2015-02-04
UA117908C2 (uk) 2018-10-25
MY175743A (en) 2020-07-07
EP2830635A4 (en) 2016-03-16
RU2014143017A (ru) 2016-05-20
ZA201406901B (en) 2017-09-27
US20150045322A1 (en) 2015-02-12
IL234689A0 (en) 2014-11-30
HK1203369A1 (en) 2015-10-30
WO2013147689A1 (en) 2013-10-03
JP2015511664A (ja) 2015-04-20
CA2868444A1 (en) 2013-10-03
CN104203256A (zh) 2014-12-10

Similar Documents

Publication Publication Date Title
EP2787497A4 (en) DEFAULT ASSESSMENT APPARATUS
EP2815691A4 (en) ENDOSCOPE
EP2692278A4 (en) Borescope
EP2820999A4 (en) ENDOSCOPE
EP2891448A4 (en) ENDOSCOPE
EP2837320A4 (en) Borescope
GB201218666D0 (en) Apparatus
EP2835093A4 (en) ENDOSCOPE
EP2868252A4 (en) Borescope
GB201218575D0 (en) Nephroureterectomy apparatus
EP2856924A4 (en) Borescope
EP2865318A4 (en) ENDOSCOPE
GB201212900D0 (en) Triage scoring system
ZA201406901B (en) Combination treatment comprising sulphated glycosaminoglycans for inducing labor
ZA201501562B (en) Treatment regimens
EP2889035A4 (en) ANTI-TUMOR AGENT
GB201215796D0 (en) Apparatus
GB201204981D0 (en) Pre-harvest treatment
IL217807A0 (en) Therapeutic compositions
EP2822545A4 (en) TREATMENT OF HIGH RATE OF CHOLESTEROL
GB201201805D0 (en) Speculum
GB2503675B (en) Brackets
GB2498997B (en) Oven cleaning system
GB201211135D0 (en) Treatment
GB201208690D0 (en) Treatment